ABBV ▼ -0.3% - AbbVie Inc.
$ABBV - AbbVie Submits Biologics License Application (BLA) for Etentamig to U.S. FDA for Adults Living With Relapsed/Refractory Multiple Myeloma
27-OCT-2026 08:02 AM ET
Share this post
More filings for $ABBV
ABBV ▼ -0.3% - AbbVie Inc.Oct 27, 2026ABBV ▲ +0.1% - AbbVie Inc.Oct 26, 2026ABBV ▲ +0.5% - AbbVie Inc.Oct 23, 2026ABBV ▲ +1.2% - AbbVie Inc.Oct 22, 2026ABBV ▼ -0.6% - AbbVie Inc.Oct 21, 2026ABBV ▲ +0.4% - AbbVie Inc.Oct 20, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment